PARIS—A partnership agreement was announced late March between Pierre Fabre Laboratories and biotech company SETUBIO within the framework of the Nature Open Library program, an original open-innovation initiative launched by Pierre Fabre to develop the therapeutic properties of the latter’s library of plants. No financial details were disclosed, but the work will leverage SETUBIO’s high-throughput biological screening platform to identify new, pharmaceutically active molecules for human and animal health.

 

“This collaboration with SETUBIO confirms the relevance of our open innovation initiative, Nature Open Library, which is aimed at exploiting all the potential of our 15,000-plant collection. It enables us to envisage the discovery of new therapeutic uses of plant extracts in sectors corresponding to or complementing our major fields of research,” said Laurent Audoly, Pierre Fabre Pharmaceuticals’ R&D director.